OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced Cancer

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2005.09.034
Authors: Anne L. Thomas, Bruno Morgan, Mark A. Horsfield, Anthony Higginson, Andrea Kay, Lucy Lee, Eric Masson, Marie Puccio-Pick, Dirk Laurent, William P. Steward
Institution: University of Leicester
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PTK787/ZK222584, VEGFR inhibitors, angiogenesis inhibitors, advanced cancer, maximum tolerated dose, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, DCE-MRI, platelet-derived growth factor receptor, CD117, oral administration
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2147178092
FWCI: 10.8
Cites: 27
Cited by: 228
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms